BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 28017306)

  • 1. Extent of pelvic lymphadenectomy and use of adjuvant vaginal brachytherapy for early-stage endometrial cancer.
    Matsuo K; Machida H; Ragab OM; Takiuchi T; Pham HQ; Roman LD
    Gynecol Oncol; 2017 Mar; 144(3):515-523. PubMed ID: 28017306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphadenectomy influences the utilization of adjuvant radiation treatment for endometrial cancer.
    Sharma C; Deutsch I; Lewin SN; Burke WM; Qiao Y; Sun X; Chao CK; Herzog TJ; Wright JD
    Am J Obstet Gynecol; 2011 Dec; 205(6):562.e1-9. PubMed ID: 22030315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stage IB endometrial cancer. Does lymphadenectomy replace adjuvant radiotherapy?
    Bottke D; Wiegel T; Kreienberg R; Kurzeder C; Sauer G
    Strahlenther Onkol; 2007 Nov; 183(11):600-4. PubMed ID: 17960334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in the utilization of adjuvant vaginal brachytherapy in women with early-stage endometrial carcinoma: Results of an updated period analysis of SEER data.
    Modh A; Ghanem AI; Burmeister C; Rasool N; Elshaikh MA
    Brachytherapy; 2016; 15(5):554-61. PubMed ID: 27475480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in the utilization of adjuvant vaginal cuff brachytherapy and/or external beam radiation treatment in stage I and II endometrial cancer: a surveillance, epidemiology, and end-results study.
    Patel MK; Cote ML; Ali-Fehmi R; Buekers T; Munkarah AR; Elshaikh MA
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):178-84. PubMed ID: 22014953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of radiation modality and lymph node dissection on survival in early-stage endometrial cancer.
    Chino JP; Jones E; Berchuck A; Secord AA; Havrilesky LJ
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1872-9. PubMed ID: 21640502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes and relapse patterns of stage IB grade 2 or 3 endometrial cancer treated with adjuvant vaginal brachytherapy.
    Hochreiter A; Kelly JR; Young MR; Litkouhi B; Black JD; Stromberger C; Higgins S; Schwartz PE; Damast S
    Int J Gynecol Cancer; 2020 Jan; 30(1):48-55. PubMed ID: 31722964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaginal brachytherapy alone is sufficient adjuvant treatment of surgical stage I endometrial cancer.
    Solhjem MC; Petersen IA; Haddock MG
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1379-84. PubMed ID: 16029796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of vaginal brachytherapy in the treatment of surgical stage I papillary serous or clear cell endometrial cancer.
    Barney BM; Petersen IA; Mariani A; Dowdy SC; Bakkum-Gamez JN; Haddock MG
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):109-15. PubMed ID: 22543202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical lymph node assessment influences adjuvant therapy in clinically apparent stage I endometrioid endometrial carcinoma, meeting Mayo criteria for lymphadenectomy.
    Pendlebury A; Radeva M; Rose PG
    J Surg Oncol; 2021 Apr; 123(5):1292-1298. PubMed ID: 33592112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant high dose rate vaginal brachytherapy as treatment of stage I and II endometrial carcinoma.
    Horowitz NS; Peters WA; Smith MR; Drescher CW; Atwood M; Mate TP
    Obstet Gynecol; 2002 Feb; 99(2):235-40. PubMed ID: 11814503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [High dose rate vaginal brachytherapy in endometrial cancer after surgery].
    Moreau-Claeys MV; Brunaud C; Hoffstetter S; Buchheit I; Peiffert D
    Cancer Radiother; 2011 Jun; 15(3):169-75. PubMed ID: 21237693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health related quality of life and symptoms after pelvic lymphadenectomy or radiotherapy vs. no adjuvant regional treatment in early-stage endometrial carcinoma: a large population-based study.
    van de Poll-Franse LV; Pijnenborg JM; Boll D; Vos MC; van den Berg H; Lybeert ML; de Winter K; Kruitwagen RF
    Gynecol Oncol; 2012 Oct; 127(1):153-60. PubMed ID: 22704950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenocarcinoma of the endometrium treated with combined irradiation and surgery: study of 437 patients.
    Touboul E; Belkacémi Y; Buffat L; Deniaud-Alexandre E; Lefranc JP; Lhuillier P; Uzan S; Jannet D; Uzan M; Antoine M; Huart J; Ganansia V; Milliez J; Blondon J; Housset M; Schlienger M
    Int J Radiat Oncol Biol Phys; 2001 May; 50(1):81-97. PubMed ID: 11316550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of systematic lymphadenectomy and adjuvant radiotherapy in node-positive endometrial cancer patients.
    Mariani A; Dowdy SC; Cliby WA; Haddock MG; Keeney GL; Lesnick TG; Podratz KC
    Gynecol Oncol; 2006 May; 101(2):200-8. PubMed ID: 16510174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant vaginal brachytherapy decreases the risk of vaginal recurrence in patients with stage I non-invasive uterine papillary serous carcinoma. A multi-institutional study.
    Mahdi H; Rose PG; Elshaikh MA; Munkarah A; Isrow D; Singh S; Waggoner S; Ali-Fehmi R; Morris RT; Harding J; DeBenardo R
    Gynecol Oncol; 2015 Mar; 136(3):529-33. PubMed ID: 25575483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stage II endometrial carcinoma: limiting post-operative radiotherapy to the vaginal vault in node-negative tumors.
    Rittenberg PV; Lotocki RJ; Heywood MS; Krepart GV
    Gynecol Oncol; 2005 Sep; 98(3):434-8. PubMed ID: 16005498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive factors of recurrence following adjuvant vaginal cuff brachytherapy alone for stage I endometrial cancer.
    Dunn EF; Geye H; Platta CS; Gondi V; Rose S; Bradley KA; Anderson BM
    Gynecol Oncol; 2014 Jun; 133(3):494-8. PubMed ID: 24657301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Survival, prognostic factors and modern tendencies in adjuvant treatment of diagnosed endometrial cancer patients with or without lymph node dissection].
    Ivanov I
    Akush Ginekol (Sofiia); 2009; 48 Suppl 1():3-11. PubMed ID: 20387272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of different adjuvant radiotherapy modalities on women with early-stage intermediate- to high-risk endometrial cancer.
    Jin M; Hou X; Sun X; Zhang Y; Hu K; Zhang F
    Int J Gynecol Cancer; 2019 Oct; 29(8):1264-1270. PubMed ID: 31320487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.